Trial Profile
A Phase Ib, Single Centre, Open Label, Parallel-Group, Controlled Study of Effects on Metabolic Control of an Oral Insulin Formulation in a Type 2 Diabetic Population.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 29 Jul 2019
Price :
$35
*
At a glance
- Drugs Insulin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Diabetology
- 27 Jul 2019 Status changed from recruiting to completed.
- 10 Dec 2015 New trial record